serine has been researched along with methylnitronitrosoguanidine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dalbadie-McFarland, G; Davis, EF; Foster, PL; Richards, JH; Schultz, SC | 1 |
| Lee, CC; Lin, HK; Lin, JK | 1 |
| Cao, L; Chodosh, LA; Deng, CX; Huber, LJ; Kim, SS; Li, C; Xu, X | 1 |
3 other study(ies) available for serine and methylnitronitrosoguanidine
| Article | Year |
|---|---|
Creation of a test plasmid for detecting G-C-to-T-A transversions by changing serine to arginine in the active site of beta-lactamase.
Topics: Aflatoxins; Amino Acid Sequence; Arginine; beta-Lactamases; Binding Sites; Methyl Methanesulfonate; Methylnitronitrosoguanidine; Mutation; Plasmids; Serine; Ultraviolet Rays | 1987 |
A reverse mutagenicity assay for alkylating agents based on a point mutation in the beta-lactamase gene at the active site serine codon.
Topics: Alkylating Agents; Amino Acid Sequence; Ampicillin Resistance; Base Sequence; beta-Lactamases; Binding Sites; Codon; DNA, Bacterial; Escherichia coli; Methylnitronitrosoguanidine; Molecular Sequence Data; Mutagenesis, Site-Directed; Mutagenicity Tests; Plasmids; Point Mutation; Salmonella typhimurium; Serine | 1994 |
Uterus hyperplasia and increased carcinogen-induced tumorigenesis in mice carrying a targeted mutation of the Chk2 phosphorylation site in Brca1.
Topics: Aging; Animals; BRCA1 Protein; Carcinogens; Cell Cycle; Cell Transformation, Neoplastic; Checkpoint Kinase 2; DNA Damage; Female; Gamma Rays; Hyperplasia; Mammary Glands, Animal; Methylnitronitrosoguanidine; Mice; Mutagenesis, Site-Directed; Mutation; Phenotype; Phosphorylation; Protein Serine-Threonine Kinases; Serine; Survival Rate; Uterus | 2004 |